Bridgeway Capital Management, LLC Talaris Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.68 - $3.22 $407,025 - $489,037	151,875 Added 101.72%	301,175 $846,000
Q2 2023 Aug 14, 2023	BUY	$1.78 - $3.2 $38,092 - $68,480	21,400 Added 16.73%	149,300 $453,000
Q1 2023 May 15, 2023	SELL	$1.09 - $2.09 $39,785 - $76,285	-36,500 Reduced 22.2%	127,900 $240,000
Q4 2022 Feb 14, 2023	BUY	$0.94 - $1.64 $143,726 - $250,755	152,900 Added 1329.57%	164,400 $167,000
Q3 2022 Nov 14, 2022	BUY	$2.3 - $5.03 $26,449 - $57,845	11,500 New	11,500 $30,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.